Published in Ophthalmology on November 11, 2012
Prediction of age-related macular degeneration in the general population: the Three Continent AMD Consortium. Ophthalmology (2013) 1.02
Switch of anti-VEGF agents is an option for nonresponders in the treatment of AMD. Eye (Lond) (2014) 1.01
VEGFA and VEGFR2 gene polymorphisms and response to anti-vascular endothelial growth factor therapy: comparison of age-related macular degeneration treatments trials (CATT). JAMA Ophthalmol (2014) 0.92
Pharmacogenetic associations with long-term response to anti-vascular endothelial growth factor treatment in neovascular AMD patients. Mol Vis (2014) 0.85
Risk factors and biomarkers of age-related macular degeneration. Prog Retin Eye Res (2016) 0.85
GWAS study using DNA pooling strategy identifies association of variant rs4910623 in OR52B4 gene with anti-VEGF treatment response in age-related macular degeneration. Sci Rep (2016) 0.82
A genetic variant in NRP1 is associated with worse response to ranibizumab treatment in neovascular age-related macular degeneration. Pharmacogenet Genomics (2016) 0.80
Diabetic retinopathy: variations in patient therapeutic outcomes and pharmacogenomics. Pharmgenomics Pers Med (2014) 0.80
Influence of seasonal sunlight intensity and iris color on the anti-VEGF therapy for neovascular age-related macular degeneration. Eye (Lond) (2013) 0.78
Vascular endothelial growth factor gene polymorphisms in age-related macular degeneration in a Turkish population. Int J Ophthalmol (2014) 0.78
Developments in Ocular Genetics: 2013 Annual Review. Asia Pac J Ophthalmol (Phila) (2015) 0.75
Predicting vision gains with anti-VEGF therapy in neovascular age-related macular degeneration patients by using low-luminance vision. Br J Ophthalmol (2015) 0.75
Worsening anatomic outcomes following aflibercept for neovascular age-related macular degeneration in eyes previously well controlled with ranibizumab. Clin Ophthalmol (2016) 0.75
Mertk gene expression and photoreceptor outer segment phagocytosis by cultured rat bone marrow mesenchymal stem cells. Mol Vis (2017) 0.75
Cellular and Molecular Pathology of Age-Related Macular Degeneration: Potential Role for Proteoglycans. J Ophthalmol (2016) 0.75
Bevacizumab treatment for neovascular age-related macular degeneration in the setting of a clinic: "real life" long-term outcome. BMC Ophthalmol (2015) 0.75
Large-scale genotyping identifies 41 new loci associated with breast cancer risk. Nat Genet (2013) 8.24
Genome-wide association studies identify four ER negative-specific breast cancer risk loci. Nat Genet (2013) 3.81
Seven new loci associated with age-related macular degeneration. Nat Genet (2013) 3.81
Genome-wide association analysis identifies three new breast cancer susceptibility loci. Nat Genet (2012) 3.20
Safety and efficacy of a flexible dosing regimen of ranibizumab in neovascular age-related macular degeneration: the SUSTAIN study. Ophthalmology (2011) 2.47
Multiple common susceptibility variants near BMP pathway loci GREM1, BMP4, and BMP2 explain part of the missing heritability of colorectal cancer. PLoS Genet (2011) 2.47
A meta-analysis of genome-wide association studies of breast cancer identifies two novel susceptibility loci at 6q14 and 20q11. Hum Mol Genet (2012) 2.45
Ancestral LOXL1 variants are associated with pseudoexfoliation in Caucasian Australians but with markedly lower penetrance than in Nordic people. Hum Mol Genet (2007) 2.42
Genome-wide meta-analyses of multiancestry cohorts identify multiple new susceptibility loci for refractive error and myopia. Nat Genet (2013) 2.36
Photodynamic therapy in practice: a review of the results of the first 12 months experience with verteporfin at the Royal Victorian Eye and Ear Hospital. Clin Experiment Ophthalmol (2003) 2.25
Therapeutic targeting of the complement system in age-related macular degeneration: a review. Clin Experiment Ophthalmol (2012) 2.03
AMD: to supplement or not? Clin Experiment Ophthalmol (2004) 2.02
Survey of prophylactic intracameral antibiotic use in cataract surgery in an Australian context. Clin Experiment Ophthalmol (2013) 1.98
Common variants near FRK/COL10A1 and VEGFA are associated with advanced age-related macular degeneration. Hum Mol Genet (2011) 1.98
Perifoveal müller cell depletion in a case of macular telangiectasia type 2. Ophthalmology (2010) 1.92
Dietary omega-3 fatty acid and fish intake in the primary prevention of age-related macular degeneration: a systematic review and meta-analysis. Arch Ophthalmol (2008) 1.75
Red meat and chicken consumption and its association with age-related macular degeneration. Am J Epidemiol (2009) 1.63
Evidence of gene-environment interactions between common breast cancer susceptibility loci and established environmental risk factors. PLoS Genet (2013) 1.56
Heritability of refractive error and ocular biometrics: the Genes in Myopia (GEM) twin study. Invest Ophthalmol Vis Sci (2006) 1.51
Acute intraocular inflammation after intravitreous injections of bevacizumab for treatment of neovascular age-related macular degeneration. Ophthalmology (2008) 1.51
Prophylactic laser treatment hastens choroidal neovascularization in unilateral age-related maculopathy: final results of the drusen laser study. Am J Ophthalmol (2006) 1.50
Dietary antioxidants and primary prevention of age related macular degeneration: systematic review and meta-analysis. BMJ (2007) 1.46
Facts on fats. Clin Experiment Ophthalmol (2006) 1.40
Identification of a rare coding variant in complement 3 associated with age-related macular degeneration. Nat Genet (2013) 1.39
Hydroxychloroquine retinopathy: screening needed to prevent blindness. Med J Aust (2010) 1.38
The epsilon2 and epsilon4 alleles of the apolipoprotein gene are associated with age-related macular degeneration. Invest Ophthalmol Vis Sci (2004) 1.34
Hypomethylation of the IL17RC promoter associates with age-related macular degeneration. Cell Rep (2012) 1.28
Apolipoprotein (APOE) gene is associated with progression of age-related macular degeneration (AMD). Hum Mutat (2006) 1.22
Variations in apolipoprotein E frequency with age in a pooled analysis of a large group of older people. Am J Epidemiol (2011) 1.19
Gene-environment interaction in progression of AMD: the CFH gene, smoking and exposure to chronic infection. Hum Mol Genet (2008) 1.17
Evidence of association of APOE with age-related macular degeneration: a pooled analysis of 15 studies. Hum Mutat (2011) 1.17
Insights into the genetic architecture of early stage age-related macular degeneration: a genome-wide association study meta-analysis. PLoS One (2013) 1.16
Heritability and genome-wide association study to assess genetic differences between advanced age-related macular degeneration subtypes. Ophthalmology (2012) 1.16
Anti-VEGF treatment in neovascular age-related macular degeneration: a treat-and-extend protocol over 2 years. Retina (2014) 1.13
Linkage to 10q22 for maximum intraocular pressure and 1p32 for maximum cup-to-disc ratio in an extended primary open-angle glaucoma pedigree. Invest Ophthalmol Vis Sci (2005) 1.13
Visual function tests as potential biomarkers in age-related macular degeneration. Invest Ophthalmol Vis Sci (2011) 1.12
Amyloid precursor protein processing and retinal pathology in mouse models of Alzheimer's disease. Graefes Arch Clin Exp Ophthalmol (2009) 1.10
Measuring rod and cone dynamics in age-related maculopathy. Invest Ophthalmol Vis Sci (2008) 1.10
Large scale international replication and meta-analysis study confirms association of the 15q14 locus with myopia. The CREAM consortium. Hum Genet (2012) 1.09
Loss of cone function in age-related maculopathy. Invest Ophthalmol Vis Sci (2003) 1.09
Androgen receptor repeat length polymorphism associated with male-to-female transsexualism. Biol Psychiatry (2008) 1.09
The SERPING1 gene and age-related macular degeneration. Lancet (2009) 1.08
Animal models of retinal disease. Prog Mol Biol Transl Sci (2011) 1.08
Fat consumption and its association with age-related macular degeneration. Arch Ophthalmol (2009) 1.08
Refinement of the associations between risk of colorectal cancer and polymorphisms on chromosomes 1q41 and 12q13.13. Hum Mol Genet (2011) 1.07
Delay to treatment and visual outcomes in patients treated with anti-vascular endothelial growth factor for age-related macular degeneration. Am J Ophthalmol (2012) 1.06
Nine loci for ocular axial length identified through genome-wide association studies, including shared loci with refractive error. Am J Hum Genet (2013) 1.06
Choroidal thickness profiles in retinitis pigmentosa. Clin Experiment Ophthalmol (2012) 1.06
The role of educational attainment in refraction: the Genes in Myopia (GEM) twin study. Invest Ophthalmol Vis Sci (2008) 1.05
Alcohol consumption and the risk of age-related macular degeneration: a systematic review and meta-analysis. Am J Ophthalmol (2008) 1.05
A genome-wide association study of early-onset breast cancer identifies PFKM as a novel breast cancer gene and supports a common genetic spectrum for breast cancer at any age. Cancer Epidemiol Biomarkers Prev (2014) 1.03
Analysis of the Y402H variant of the complement factor H gene in age-related macular degeneration. Invest Ophthalmol Vis Sci (2006) 1.03
Meta-analysis of genome-wide association studies in five cohorts reveals common variants in RBFOX1, a regulator of tissue-specific splicing, associated with refractive error. Hum Mol Genet (2013) 1.01
The prevalence estimates of macular telangiectasia type 2: the Melbourne Collaborative Cohort Study. Retina (2010) 1.00
Genetic influences on the outcome of anti-vascular endothelial growth factor treatment in neovascular age-related macular degeneration. Ophthalmology (2013) 1.00
Refractive errors in twin studies. Twin Res Hum Genet (2006) 1.00
A silk-based scaffold platform with tunable architecture for engineering critically-sized tissue constructs. Biomaterials (2012) 0.99
New treatments in age-related macular degeneration. Clin Experiment Ophthalmol (2003) 0.99
Iris colour, ethnic origin and progression of age-related macular degeneration. Clin Experiment Ophthalmol (2003) 0.99
Technical considerations for genotyping multi-allelic copy number variation (CNV), in regions of segmental duplication. BMC Genomics (2014) 0.98
A tag-single nucleotide polymorphisms approach to the vascular endothelial growth factor-A gene in age-related macular degeneration. Mol Vis (2007) 0.98
Geographic atrophy in age-related macular degeneration and TLR3. N Engl J Med (2009) 0.97
Identification of urinary biomarkers for age-related macular degeneration. Invest Ophthalmol Vis Sci (2011) 0.97
Impact of cataract surgery on quality of life in patients with early age-related macular degeneration. Optom Vis Sci (2007) 0.96
Explaining variance in the cumulus mammographic measures that predict breast cancer risk: a twins and sisters study. Cancer Epidemiol Biomarkers Prev (2013) 0.96
Effect of posterior juxtascleral triamcinolone acetonide on choroidal neovascular growth after photodynamic therapy with verteporfin. Ophthalmology (2005) 0.96
Abdominal obesity and age-related macular degeneration. Am J Epidemiol (2011) 0.95
Impact of keratoconus in the better eye and the worse eye on vision-related quality of life. Invest Ophthalmol Vis Sci (2014) 0.95
C-reactive protein levels and complement factor H polymorphism interaction in age-related macular degeneration and its progression. Ophthalmology (2010) 0.95
Clinical validation of a genetic model to estimate the risk of developing choroidal neovascular age-related macular degeneration. Hum Genomics (2011) 0.95